Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-04

Clinical Trial Update: A Study to Evaluate the Bioavailability of Teduglutide Administered Subcutaneously by Syringe Injection Versus Pen Injector in Healthy Adult Participants [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing the bioavailability of teduglutide when administered subcutaneously by syringe injection vs. a pen injector in healthy adult volunteer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teduglutide (teduglutide)

Snippet

Sponsor: Shire | Conditions: Healthy Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2022-10-04